Home >
Investors & Media
Text Size make text size smaller make text size larger Print print this page

Investors & Media

Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs. We believe the quality and breadth of our product candidate pipeline, platform technology, strategic collaborations and scientific team will enable us to become a fully integrated biopharmaceutical company with a diversified portfolio of novel therapeutics for major diseases.

NASDAQ:SNSS ANNUAL REPORT
1:14 PM ET Jul 3, 2008
Price $1.42
Change + 0.02
Day Range $1.36 - $1.42
Volume 3,400

Market data powered by TurboFeed.
Delayed at least 15 minutes.

Get a detailed stock quote
2007 Annual Report and Form 10-K
(  PDF, 540.3 KB)
CORPORATE PRESENTATION
Corporate Presentation
(  PDF, 537.9 KB)

Latest News

Calendar of Events

callout title graphic
Sunesis is an innovative biopharmaceutical company focused on therapeutics for oncology and other unmet medical needs.
Recent Webcasts
Listen to recent webcasts of presentation conference calls, earnings calls, and more.